Market Cap : 482.94 M | Enterprise Value : 417.24 M | PE Ratio : 14.20 | PB Ratio : 7.55 |
---|
NAS:GRNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:GRNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GreenLight Biosciences has the Profitability Rank of 1. It has had trouble to make a profit.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %GreenLight Biosciences's Operating Margin % for the quarter that ended in Mar. 2022 was %. As of today, GreenLight Biosciences's Piotroski F-Score is 9999.
For the Biotechnology subindustry, GreenLight Biosciences's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, GreenLight Biosciences's Profitability Rank distribution charts can be found below:
* The bar in red indicates where GreenLight Biosciences's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
GreenLight Biosciences has the Profitability Rank of 1. It has had trouble to make a profit.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
GreenLight Biosciences's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:
Operating Margin % | = | Operating Income (Q: Mar. 2022 ) | / | Revenue (Q: Mar. 2022 ) |
= | -36.779 | / | 0 | |
= | % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
GreenLight Biosciences has an F-score of 9999. It is a bad or low score, which usually implies poor business operation.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of GreenLight Biosciences's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Keefe Susan | officer: CFO & Interim CAO | C/O SERACARE LIFE SCIENCES, INC. 375 WEST STREET WEST BRIDGEWATER MA 02379 |
Obrien Eric | director, 10 percent owner | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Walker Matthew Alan | director, 10 percent owner | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Schlicher Martha | director | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Singleton Mark | officer: VP of Technology | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Khan Amin | officer: Chief Scientific Officer | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Ortega-valle Marta | officer: Chief Business Officer | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Manocha Charu | officer: Chief People Officer | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155 |
Pardi Jennifer E | director | 99 HIGH STREET, 12TH FLOOR BOSTON MA 02110 |
Builders Vision Llc | 10 percent owner | 110 NW 2ND STREET SUITE 300 BENTONVILLE AR 72712 |
Kennedy David | officer: General Counsel & Secretary | 3030 ORCHARD PARKWAY SAN JOSE CA 95134 |
Cobb Carole B | officer: Chief Operating Officer | |
Mvil, Llc | 10 percent owner | 22ND FLOOR HANG LUNG CENTRE 2-20 PATERSON STREET CAUSEWAY BAY K3 00000 |
Cooney Charles L | director | C/O POLYPORE INTERNATIONAL, INC. 11430 N. COMMUNITY HOUSE ROAD, SUITE 350 CHARLOTTE NC 28277 |
Zarur Juan Andrey | director, officer: President & CEO | C/O SOLID BIOSCIENCES, LLC 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 |
From GuruFocus